Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 8:25 pm Sale | 2024-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | Forward Ventures V, LP | 847,600 4.300% | -1,719,922 (-66.99%) | Filing History |
| 2024-02-13 9:04 pm Sale | 2023-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | Forward Ventures V, LP | 2,567,522 6.650% | -97,268 (-3.65%) | Filing History |
| 2022-02-09 5:24 pm Purchase | 2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | Forward Ventures V, LP | 2,664,790 7.140% | 42,516 (+1.62%) | Filing History |
| 2021-03-08 5:05 pm Purchase | 2021-02-25 | 13G | Viracta Therapeutics, Inc. VIRX | Forward Ventures V, LP | 2,622,274 7.090% | 2,622,274 (New Position) | Filing History |